Noncoding RNAs in Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)
National Institutes of Health
Posted on:
Type
Research/project funding
Funding Opportunity RFA-AG-23-010 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to stimulate research in noncoding ribonucleic acids (ncRNAs) to investigate the causality, directionality, mechanisms, and therapeutic potential of ncRNAs in Alzheimer's disease and Alzheimer's disease related dementias (AD/ADRD). This FOA will support applications seeking to discover novel mechanisms mediated by ncRNAs, elucidate molecular, and cellular functions involved in the pathogenesis and progression of AD/ADRD.